Abstract:The downregulation of SIRT1 in the SDH, following CCI, leads to increased histone H3 acetylation in the Scn3a promoter region. This promotes the expression of Nav1.3, which subsequently causes CaMKIIα+ neurons activation, resulting in pain. Alleviating pain by reversing SIRT1 downregulation can be a potential therapeutic target for local spinal cord analgesics. Aims Neuropathic pain is a common chronic pain disorder, which is largely attributed to spinal central sensitization. Calcium/calmodulin‐dependent protein kinase II alpha (CaMKIIα) activation in the spinal dorsal horn (SDH) is a major contributor to spinal sensitization. However, the exact way that CaMKIIα‐positive (CaMKIIα+) neurons in the SDH induce neuropathic pain is still unclear. This study aimed to explore the role of spinal CaMKIIα+ neurons in neuropathic pain caused by chronic constriction injury (CCI) and investigate the potential epigenetic mechanisms involved in CaMKIIα+ neuron activation. Methods CCI‐induced neuropathic pain mice model, Sirt1loxP/loxP mice, and chemogenetic virus were used to investigate whether the activation of spinal CaMKIIα+ neurons is involved in neuropathic pain and its involved mechanism. Transcriptome sequence, western blotting, qRT‐PCR, and immunofluorescence analysis were performed to assay the expression of related molecules and activation of neurons. Co‐immunoprecipitation was used to observe the binding relationship of protein. Chromatin immunoprecipitation (ChIP)‐PCR was applied to analyze the acetylation of histone H3 in the Scn3a promoter region. Results The expression of sodium channel Nav1.3 was increased and the expression of SIRT1 was decreased in the spinal CaMKIIα+ neurons of CCI mice. CaMKIIα neurons became overactive after CCI, and inhibiting their activation relieved CCI‐induced pain. Overexpression of SIRT1 reversed the increase of Nav1.3 and alleviated pain, while knockdown of SIRT1 or overexpression of Nav1.3 promoted CaMKIIα+ neuron activation and induced pain. By knocking down spinal SIRT1, the acetylation of histone H3 in the Scn3a (encoding Nav1.3) promoter region was increased, leading to an increased expression of Nav1.3. Conclusion The findings suggest that an aberrant reduction of spinal SIRT1 after nerve injury epigenetically increases Nav1.3, subsequently activating CaMKIIα+ neurons and causing neuropathic pain.

Chemokine Receptor CXCR4 Regulates CaMKII/CREB Pathway in Spinal Neurons That Underlies Cancer-Induced Bone Pain

Chemokine Receptor CXCR4 Activates the RhoA/ROCK2 Pathway in Spinal Neurons That Induces Bone Cancer Pain

CREB-regulated Transcription Coactivator 1 Enhances CREB-dependent Gene Expression in Spinal Cord to Maintain the Bone Cancer Pain in Mice.

Role of the CXCR4/ALK5/Smad3 Signaling Pathway in Cancer-Induced Bone Pain

Schwann Cell-Derived CXCL2 Contributes to Cancer Pain by Modulating Macrophage Infiltration in a Mouse Breast Cancer Model

Nuclear Factor Kappa B Regulated Monocyte Chemoattractant Protein-1/Chemokine CC Motif Receptor-2 Expressing in Spinal Cord Contributes to the Maintenance of Cancer-Induced Bone Pain in Rats.

Positive Feedback Regulation Between Microrna‐132 and CREB in Spinal Cord Contributes to Bone Cancer Pain in Mice

Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord

Downregulated CAV-1 in Mouse Spinal Cord May Alleviate Bone Cancer Pain by Inhibiting the ERK/CREB Pathway.

Extracellular Signal-Regulated Kinase Activation in Spinal Astrocytes and Microglia Contributes to Cancer-Induced Bone Pain in Rats

The Role Of Ca2+/Calmodulin-Dependent Protein Kinase Ii-Cyclic Amp-Responsive Element Binding Protein Signaling Pathway On Sensory-Discriminative And Affective-Motivational Pain Responses In A Rat Model Of Chronic Constriction Injury Of Sciatic Nerve

Role of Spinal CX3CR1 in Inflammatory Pain in Mice:The Relationship with CaM-CaMKⅡ Signaling Pathways

Spinal Ifn-Gamma-Induced Protein-10 (Cxcl10) Mediates Metastatic Breast Cancer-Induced Bone Pain By Activation Of Microglia In Rat Models

Activation of the BMP2-SMAD1-CGRP Pathway in Dorsal Root Ganglia Contributes to Bone Cancer Pain in a Rat Model

Suppression of KCNQ/M (kv7) Potassium Channels in the Spinal Cord Contributes to the Sensitization of Dorsal Horn WDR Neurons and Pain Hypersensitivity in a Rat Model of Bone Cancer Pain.

The Inhibitor of Calcium/calmodulin-Dependent Protein Kinase II KN93 Attenuates Bone Cancer Pain Via Inhibition of KIF17/NR2B Trafficking in Mice

Down-Regulation of Toll-Like Receptor 4 Gene Expression by Short Interfering RNA Attenuates Bone Cancer Pain in a Rat Model

Changes in protein expression and distribution of spinal CCR2 in a rat model of bone cancer pain.

SIRT1 mediates the excitability of spinal CaMKIIα‐positive neurons and participates in neuropathic pain by controlling Nav1.3

Brain‐derived Neurotrophic Factor Modulates N‐methyl‐D‐aspartate Receptor Activation in a Rat Model of Cancer‐induced Bone Pain

Involvement of the Spinal NMDA Receptor/pkcγ Signaling Pathway in the Development of Bone Cancer Pain